889. Deputy Martin Daly asked the Minister for Health if Veoza, aimed at women who are not suitable for HRT, will be covered under the free HRT scheme; and if she will make a statement on the matter. [37881/25]
Topics / Medicinal Products
A subject heading for parliamentary questionsMedicinal Products
1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.
1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked
Questions per month
The record holds no questions for August, when the Dáil does not sit.
Jan 2025Oct 2026
Show as a table
| Month | Questions |
|---|---|
| January 2025 | 17 |
| February 2025 | 66 |
| March 2025 | 28 |
| April 2025 | 35 |
| May 2025 | 43 |
| June 2025 | 58 |
| July 2025 | 56 |
| August 2025 | 0 |
| September 2025 | 36 |
| October 2025 | 38 |
| November 2025 | 58 |
| December 2025 | 27 |
| January 2026 | 18 |
| February 2026 | 70 |
| March 2026 | 142 |
| April 2026 | 87 |
| May 2026 | 156 |
| June 2026 | 127 |
| July 2026 | 82 |
| August 2026 | 0 |
| September 2026 | 62 |
| October 2026 | 27 |
Who asks, by party
The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.
The TDs who asked most
Members of the Government answer questions rather than ask them. Each question counts once.
-
196
-
75
-
43
-
42
-
39
-
26
-
26
-
26
Asked of
Debated under the same heading
Debates whose official heading is exactly these words.
The questions
346. Deputy Peadar Tóibín asked the Minister for Health if she allow for Mounjaro to be accessed on the medical card (details supplied). [36712/25]
223. Deputy Michael Healy-Rae asked the Minister for Health her views on the Medicines Management Programme plan to move all high protein oral supplements to List B; and if she will make a statement on the matter. [36243/25]
256. Deputy Cathal Crowe asked the Minister for Health if she will instruct the HSE to cease plans to move all high-protein oral nutritional supplements to list B (details supplied); and if she will make a statement on the matter. [36459/25]
679. Deputy Seán Canney asked the Minister for Health if the anti-sickness drug akynzeo can be made available on the GMS as it is the only effective anti-sickness medication for many cancer patients, including those with a brain tumour; if she is aware that the cost of buying this medical monthly is placing financial strain on families already dealing with illness; and if she will make a statement on the matter. [352…
740. Deputy Peadar Tóibín asked the Minister for Health the protocols in place to review and adjust thyroid medication dosages for women following childbirth, particularly where the dosage was increased during pregnancy; in the absence of protocols, the measures that will be taken to ensure that postnatal thyroid treatment is appropriately monitored to avoid adverse effects such as depression and suicidal ideation; a…
741. Deputy Peadar Tóibín asked the Minister for Health if she is aware of cases in which women have remained on elevated thyroid medication postpartum without review, resulting in serious mental health side effects including depression and suicidal thoughts; and if the HSE has conducted or will conduct any review or audit into such cases. [35519/25]
742. Deputy Peadar Tóibín asked the Minister for Health the clinical guidelines currently in place for general practitioners and endocrinologists regarding the monitoring and adjustment of thyroid hormone levels in postpartum women; and if updated guidance will be issued to ensure safer prescribing practices. [35520/25]
772. Deputy Claire Kerrane asked the Minister for Health if a full HTA application for the drug Veoza has been submitted, and when it is anticipated the HTA will be complete; and if she will make a statement on the matter. [35598/25]
785. Deputy Richard Boyd Barrett asked the Minister for Health the estimated full-year cost of introducing a fully funded universal contraception scheme; and if she will make a statement on the matter. [35677/25]
786. Deputy Richard Boyd Barrett asked the Minister for Health the estimated annual cost of free hormone replacement therapy for anyone who needs it; and if she will make a statement on the matter. [35678/25]
7. Deputy Shane Moynihan asked the Minister for Health if the Belgian model is being examined in the context of the programme for Government commitment to investigate early access schemes for rare disease treatments; and if she will make a statement on the matter. [34617/25]
66. Deputy William Aird asked the Minister for Health the current status of access to spinal muscular atrophy (SMA) treatments for adult patients; if she will commit to ensuring equitable public reimbursement of therapies for adults living with SMA; considering the urgent need expressed by patient groups; and if she will make a statement on the matter. [34829/25]
70. Deputy Conor D. McGuinness asked the Minister for Health if she will implement a plan to support individuals with Duchenne muscular dystrophy, including the development of specialist multidisciplinary teams, and ensuring enhanced and immediate access to givinostat and similar treatments. [34818/25]
95. Deputy Pádraig O'Sullivan asked the Minister for Health the progress her Department has made in honouring the Programme for Government commitment that an early access programme for medicines would be established; and if she will make a statement on the matter. [34979/25]
197. Deputy Colm Burke asked the Minister for Health if she will prioritise the Programme for Government commitment to investigate early access schemes for orphan medicines; and if she will make a statement on the matter. [34701/25]
787. Deputy Robert O'Donoghue asked the Minister for Health if there are plans to change the timely access to the drug givinostat required to help treatment for persons with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33827/25]
799. Deputy Martin Daly asked the Minister for Health if there are plans to introduce skyclarys (omaveloxolone) into the Irish market for the treatment of Friedreich's ataxia in adults and adolescents; which is approved in America, Canada, UK, some European countries but not Ireland to date; and if she will make a statement on the matter. [33909/25]
832. Deputy Willie O'Dea asked the Minister for Health if she will accelerate the approval and funding of the new drug givinostat to treat the one-hundred boys currently living with Duchenne muscular dystrophy in Ireland; and if she will make a statement on the matter. [34122/25]
385. Deputy Robert O'Donoghue asked the Minister for Health if she will address the situation regarding the unavailability of phyllocontin and uniphyllin (theophylline) tablets, which were previously used to manage asthma and were covered under the medical card scheme; if uniphyllin continus PR, which is believed to be the replacement, will be made available under the medical card given its high monthly cost; and if …
388. Deputy Aisling Dempsey asked the Minister for Health the actions she will take to ensure that givinostat is available at the earliest opportunity to sufferers of Duchenne muscular dystrophy. [33245/25]
402. Deputy Albert Dolan asked the Minister for Health if she will provide an update on the current status of the approval process for the drug givinostat for patients with Duchenne muscular dystrophy; if consideration is being given to its inclusion in an early access programme, similar to those operating in the United Kingdom and the United States; and if she will make a statement on the matter. [33312/25]
403. Deputy Ruth Coppinger asked the Minister for Health to outline her engagements with the HSE on access to givinostat for Duchenne muscular dystrophy; and if she will make a statement on the matter. [33325/25]
412. Deputy Eoin Ó Broin asked the Minister for Health if she will use her power to ensure a decision is made as a matter of urgency regarding an application for reimbursement of new medicines (details supplied) given lengthy reimbursement times and the detrimental impact delaying access to this medicine has on the medical condition to which it relates. [33380/25]
423. Deputy Barry Heneghan asked the Minister for Health the steps she is taking to ensure that a drug (details supplied) will be assessed and made available as quickly as possible following its recent EU approval, given how important early access is for children with Duchenne muscular dystrophy; and if she will make a statement on the matter. [33451/25]